APPLIKATIONSBEHÄLTER

Patent europeic · EP3819231 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3819231
Numer da la dumonda
EP19812624
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
27-05-2019
Publitgà
12-05-2021
Concedì
10-01-2024
La protecziun finescha il pli tard
26-05-2039
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
A45D 34/04 (2006.01)
B65D 47/42 (2006.01)
B43K 1/12 (2006.01)
B43K 5/18 (2006.01)
B43K 8/12 (2006.01)
B43K 23/12 (2006.01)
B43M 11/06 (2006.01)
Prioritad
JP 2018105125 31.05.2018
JP 2018135943 19.07.2018
Dumonda PCT
PCT/JP2019/020799 27.05.2019
Publicaziun PCT
WO2019/230619 05.12.2019
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2026

    Midada

    Published in Swissreg on 01.06.2026

  2. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  3. 20-11-2024

    Midada

    Published in Swissreg on 20.11.2024

  4. 02-06-2024

    Midada

    Published in Swissreg on 02.06.2024

  5. 03-04-2024

    Represchentant inscrit

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 03.04.2024

  6. 10-01-2024

    Concedì

    Published in Swissreg on 10.01.2024

Partidas

Possessur

Sato Pharmaceutical Co., Ltd.

5-27 Motoakasaka 1-chome Minato-ku, Tokyo 107-0051, JP

Represchentant

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventur

SAKATA Kota

Tokyo 136-8531, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.